Weil am Rhein, Germany

Adrian Schmidt

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Novartis Ag. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Adrian Schmidt

Introduction

Adrian Schmidt is a notable inventor based in Weil am Rhein, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the preparation of granules. His innovative methods have the potential to enhance the efficiency of drug formulation processes.

Latest Patents

Adrian Schmidt holds a patent for a "Method for preparing granules." This method involves preparing a slurry containing solid active pharmaceutical ingredient (API) powder particles dispersed in a liquid. The slurry is then fed to a granulator, where it is mixed with a dry base powder to produce a slurry/base powder mixture. This mixture is subsequently dried to obtain granules that contain both the solid API particles and the base powder. This innovative approach can significantly improve the quality and consistency of pharmaceutical granules.

Career Highlights

Adrian Schmidt is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to apply his expertise in pharmaceutical sciences and contribute to the development of advanced drug delivery systems. His dedication to innovation has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Adrian has collaborated with several talented professionals, including Markus Krumme and Hans De Waard. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical technology.

Conclusion

Adrian Schmidt's contributions to the field of pharmaceutical technology, particularly through his patented method for preparing granules, highlight his innovative spirit and commitment to advancing drug formulation processes. His work at Novartis AG and collaborations with esteemed colleagues further underscore his impact in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…